0591-2520
Generic: chlorzoxazone
Labeler: actavis pharma, inc.Drug Facts
Product Profile
Brand Name
Generic Name
chlorzoxazone
Labeler
actavis pharma, inc.
Dosage Form
TABLET
Active Ingredients
chlorzoxazone 500 mg/1
Identifiers & Regulatory
Product NDC
0591-2520
Product ID
0591-2520_b79e689c-952a-48ee-9b76-f386a566936a
Product Type
DRUG FOR FURTHER PROCESSING
Marketing Category
DRUG FOR FURTHER PROCESSING
Listing Expiration
2026-12-31
Marketing Start
2011-08-22
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05912520
Hyphenated Format
0591-2520
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
chlorzoxazone (source: label)
Generic Name
chlorzoxazone (source: ndc)
Application Number
ANDA089859 (source: label)
Routes
source: label
Resolved Composition
Strengths
- 500 mg/1
Packaging
- 14080 TABLET in 1 BOX (0591-2520-00)
- 16896 TABLET in 1 CONTAINER (0591-2520-77)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "b79e689c-952a-48ee-9b76-f386a566936a", "openfda": {}, "finished": false, "packaging": [{"description": "14080 TABLET in 1 BOX (0591-2520-00)", "package_ndc": "0591-2520-00", "marketing_start_date": "22-AUG-11"}, {"description": "16896 TABLET in 1 CONTAINER (0591-2520-77)", "package_ndc": "0591-2520-77", "marketing_start_date": "22-JUL-24"}], "product_id": "0591-2520_b79e689c-952a-48ee-9b76-f386a566936a", "dosage_form": "TABLET", "product_ndc": "0591-2520", "generic_name": "Chlorzoxazone", "labeler_name": "Actavis Pharma, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "CHLORZOXAZONE", "strength": "500 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20110822", "listing_expiration_date": "20261231"}